Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cytarabine hydrochloride

Cytarabine hydrochloride

pharmaceutical raw materials
Cytarabine hydrochloride structure

Cytarabine hydrochloride 

structure
  • CAS No:

    69-74-9

  • Formula:

    C9H13N3O5.ClH

  • Chemical Name:

    Cytarabine hydrochloride

  • Synonyms:

    2(1H)-Pyrimidinone,4-amino-1-β-D-arabinofuranosyl-,hydrochloride (1:1);Cytosine,1-β-D-arabinofuranosyl-,monohydrochloride;2(1H)-Pyrimidinone,4-amino-1-β-D-arabinofuranosyl-,monohydrochloride;U 19920A;1-β-D-Arabinofuranosylcytosine hydrochloride;Cytarabine hydrochloride;Cytosine arabinoside hydrochloride;Aracytidine hydrochloride;1-β-D-Arabinofuranosylcytosine monohydrochloride;Arabinofuranosylcytosine hydrochloride;Arabinosylcytosine hydrochloride;Spongocytidine-hydrochloride

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Cytarabine hydrochloride is an antimetabolic agent and DNA synthesis inhibitor with IC50 of 16 nM.


Crystals (from aqueous ethanol) or fluffy white powder. (NTP, 1992)


Crystals (from aqueous ethanol) or fluffy white powder. (NTP, 1992)|Cytarabine Hydrochloride is the hydrochloride form of cytarabine, an antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair.|A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)

Cytarabine hydrochloride Basic Attributes

279.68

279.062195

200-713-9

33K3DB6591

DTXSID5024891

C71603

2942000000

Characteristics

129

-1.17980

White to off-white crystalline

186-188 °C

545.7°C at 760 mmHg

283.8ºC

greater than or equal to 100 mg/mL at 63° F (NTP, 1992)

2-8°C

Peritoneal-rat LD50: 5500 mg/kg; oral-mouse LD50: 826 mg/kg

Flammable; burning produces toxic nitrogen oxides and chloride fumes

Water soluble. Hydrolysis occurs readily, especially with acid.

Alcohols and Polyols

CYTARABINE HYDROCHLORIDE undergoes decomposition in acidic solutions.

Safety Information

IRRITANT

NONH for all modes of transport

3

36-43-63

26-36/37

HA5500000

Xn

Warehouse ventilated, low temperature and dry

Stable. Combustible. Incompatible with strong oxidizing agents.

P280-P305 + P351 + P338

H317-H319-H341-H361

Flash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)

|Warning|H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]|P201, P202, P261, P264, P272, P280, P281, P302+P352, P305+P351+P338, P308+P313, P321, P333+P313, P337+P313, P363, P405, and P501|Aggregated GHS information provided by 40 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Fires involving this material may be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: You should store this material in a refrigerator. (NTP, 1992)

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxicity

moderately toxic

Drug Information

Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)|Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)|Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

SYMPTOMS: Symptoms of exposure to this compound include leukopenia, thrombocytopenia, anemia, megaloblastosis, hepatic dysfunction, thromobophlebitis at the site of injection, and conjunctivitis. Other symptoms include potent bone marrow suppression, reduced reticulocytes, anorexia, nausea, vomiting, diarrhea, oral and anal inflammation or ulceration, fever, rash, bleeding (all sites), sepsis, pneumonia, cellulitis at injection site, skin ulceration, urinary retention, renal dysfunction, neuritis, neural toxicity, sore throat, esophageal ulceration, esophagitis, chest pain, bowel necrosis, abdominal pain, freckling, jaundice, dizziness, alopecia, allergic edema, anaphylaxis, pruritus, shortness of breath, urticaria and headache. "Flu-like" syndrome may occur. Joint pains may also occur. Eye irritation has been reported. Other eye effects include reversible glittering opacities, pain, punctuate epithelial keratitis and photophobia. ACUTE/CHRONIC HAZARDS: This compound may cause eye irritation. When heated to decomposition it emits toxic fumes of nitrogen oxides and hydrogen chloride. (NTP, 1992)

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)

Ara C

Cytarabine hydrochloride Use and Manufacturing

Methods of Manufacturing

Method 1. Preparation of 5'-cytidine-phosphate (5'-CMP) as raw material cytosine nucleoside hydrochloride 100g of 5'-cytidine-phosphate is suspended in 800ml of distilled water, and about 50ml of concentrated ammonia is added to adjust the pH value It is 8-9, the insoluble matter can be removed by filtration. After diluting to 1L, add 1L of lanthanum hydroxide gel, heat up to 90℃ and stir to hydrolyze (the end point of the reaction can be determined by electrophoresis analysis of lanthanum hydroxide gel during hydrolysis), When the 5'-cytidine-phosphate spots on the electrophoresis paper disappeared and cytosine spots appeared (about 25h), the reaction was over, centrifuged to obtain the supernatant, the precipitate was washed twice with 6L distilled water and centrifuged, and the washing solution Mix with the supernatant. Concentrate under reduced pressure, filter to remove insolubles during concentration, stop after concentrating to about 0.2L, cool down, adjust pH to 2.5-3 with 6mol/L hydrochloric acid, that is, white crystals will precipitate out, add 100ml 95% ethanol, cool overnight in refrigerator Filter and wash with dilute alcohol and absolute ethanol to obtain the product. Preparation of 5'-cytidine-phosphate [ammonia, lanthanum hydroxide]→[pH8-9, 90℃, 25h] cytosine nucleoside hydrochloride and cytosine arabinoside 30ml of cold distilled water, with the release of hydrochloric acid gas, after 5 minutes, put the reaction solution in an ice salt bath for 30 minutes. Add 2L of ethyl acetate and 40g of cytosine nucleoside hydrochloride, and reflux in a hot water bath at 80°C for about 40-50 minutes. The reaction solution was poured into 4L of distilled water, and ethyl acetate was evaporated under reduced pressure at 50°C. Adjust the pH of the concentrated solution to 3-3.5 with sodium hydroxide solution, add concentrated ammonia, hydrolyze at 80°C for 10 minutes, and filter to remove insoluble materials. Adjust the pH of the filtrate to 2.5-3, load it on an activated carbon column, and elute with distilled water at pH 3 and 50% ethanol-1% ammonia water at 60°C. Concentrate the eluate to about 20ml, adjust the pH to 3, and add ethanol to cool Crystallize and filter to obtain the product. Cytosine nucleoside hydrochloride [phosphorus oxychloride, ethyl acetate, water]→[0-80℃, 40-50min] 2, 2'-oxygen bridge-3', 5'-diacetyl cytosine nucleus Glycoside hydrochloride [ammonia] → [80℃, 10min] Preparation of cytarabine cytarabine hydrochloride Add 22g cytarabine cytarabine to 2% hydrochloric acid-methanol 440ml and methanol 220ml, and heat to dissolve in a water bath at 50℃. The activated carbon was decolorized for half an hour, filtered, concentrated, cooled overnight in the refrigerator, filtered to obtain a crude product, and recrystallized with 30 times methanol to obtain a pure product. Cytarabine [hydrochloric acid, methanol]→[50℃, 30min] Cytarabine hydrochloride Method 2. Preparation of D-arabinose using calcium gluconate as raw material The feed is calcium gluconate (m): iron sulfate ( m): Anhydrous barium acetate (m): water (V): hydrogen peroxide (V)=1:0.077:0.14:13:1.2-1.3. After the calcium gluconate is heated and dissolved in water, add the pre-prepared mixture of barium acetate solution and ferric sulfate solution, stir and raise the temperature to 95°C, filter to remove insolubles, and add half the amount of hydrogen peroxide to the filtrate and react at 40-56°C for 30 minutes , Let stand for 30min, then add the remaining hydrogen peroxide at 40℃ to react for 30min, add oxalic acid and filter to remove calcium oxalate, the filtrate is concentrated under 50℃ under vacuum, add anhydrous methanol to dissolve the crystals, filter to obtain crude product, methanol recrystallization to obtain pure product . Calcium gluconate [barium acetate, iron sulfate, hydrogen peroxide]→[40-56℃, 1.5 h] D-arabinose 2-amino-D-arabinose-oxazoline preparation feed ratio is D-arabinose ( m): Cyanamide (m): Ammonia (V): Methanol (V)=1:0.56:0.3-0.35:3-4. Dissolve cyanamide in methanol to make a 15%-20% solution, add D-arabinose and ammonia, slowly heat to an internal temperature of 51-62°C (about 1h) with stirring, keep it warm for 30min and then stir and leave for 2h. Leave it overnight and filter to obtain the product. D-arabinose [cyanamide, ammonia, methanol] → [57-62℃, 30min] 2-amino-D-arabinose-oxazoline cytarabine hydrochloride, the feed ratio is propynyl cyanide (m ): 2-Amino-D-arabinose-oxazoline (m): dimethylacetamide (m): ammonia (1 mol/L, V)=1:3.25:10:40-50. Mix 2-amino-D-arabinose-oxazoline and dimethylacetamide, cool to 5℃ under stirring, add dropwise a mixture of propargyl cyanide and a small amount of dimethylacetamide, control the dropping speed so that the temperature does not change When the temperature is over 10℃, after dripping, stir the reaction at 25℃ for 30min, filter, add ammonia water and stir for 10min at 60℃ for the filtrate, distill under reduced pressure below 60℃ to remove water, and adjust the pH to the concentrated solution with hydrochloric acid methanol solution (3%-5%) 4. Cool to precipitate crystals, filter to obtain crude product, refine with 20-50 times methanol, add activated carbon to decolorize, obtain cytarabine hydrochloride. 2-Amino-D-arabinose-oxazoline [propynyl cyanide, dimethylacetamide]→[25℃, 30min] cyclocytidine [ammonia, hydrochloric acid-methanol solution]→[pH4]arabinoside Acid salt.

Uses

Used for acute leukemia, also used for head and neck squamous cell carcinoma, externally for viral keratitis and epidemic conjunctivitis, etc.

Computed Properties

Molecular Weight:279.68
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:2
Exact Mass:279.0621982
Monoisotopic Mass:279.0621982
Topological Polar Surface Area:129
Heavy Atom Count:18
Complexity:383
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a pyrimidine anti-metabolite drug that mainly acts on cells in the S proliferation phase. It interferes with cell proliferation by inhibiting the synthesis of cell DNA. After entering the human body, cytarabine is phosphorylated by kinase and converted into cytarabine triphosphate and cytarabine diphosphate. The former can strongly inhibit the synthesis of DNA polymerase, and the latter can inhibit the conversion of cytidine diphosphate to deoxycytidine diphosphate, thereby inhibiting cell DNA polymerization and synthesis. This product is a cell cycle-specific drug, which is most sensitive to cells in the S proliferation phase, and has a weaker effect on inhibiting RNA and protein synthesis.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Cytarabine hydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.